1. Home
  2. XAIR vs IRIX Comparison

XAIR vs IRIX Comparison

Compare XAIR & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.73

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.14

Market Cap

20.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XAIR
IRIX
Founded
2011
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
20.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
XAIR
IRIX
Price
$0.73
$1.14
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
138.8K
86.5K
Earning Date
02-09-2026
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,802,000.00
$50,647,000.00
Revenue This Year
$128.45
$9.61
Revenue Next Year
$153.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
147.74
4.58
52 Week Low
$0.67
$0.78
52 Week High
$10.40
$1.87

Technical Indicators

Market Signals
Indicator
XAIR
IRIX
Relative Strength Index (RSI) 23.80 58.35
Support Level $0.67 $1.10
Resistance Level $1.31 $1.24
Average True Range (ATR) 0.06 0.07
MACD -0.00 0.02
Stochastic Oscillator 11.98 63.08

Price Performance

Historical Comparison
XAIR
IRIX

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: